Publication of the « Panorama de droit pharmaceutique 2021 » of the Revue Générale de droit Médical. Jean-Baptiste Leca discusses the access to data obtained from pharmacological and clinical trials in light of the French Trade Secret Law and recent CJEU case law.
Read the article here